Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Daiichi Sankyo has taken blows recently from regulatory and commercial setbacks, but the company’s diversified oncology and cardiovascular franchises, plus sizable biologics manufacturing capabilities, create a path to recovery. The sell-off looks disproportionate to the underlying value of the pipeline and manufacturing assets. This trade idea out…
Citizens raised its price objective on Affirm Holdings Inc. to $105 while keeping a Market Outperform rating, citing projected gross merchandise volume growth and an eventual net margin profile similar to Discover Financial Services. The new target, based on a five-year forecast through fiscal 2030 and a series of valuation assumptions, implies rou…
Barclays has reduced its rating on Rio Tinto plc from Overweight to Equal Weight and lowered its price target to 6,600p from 6,885p, citing a tighter valuation framework and softer near-term iron ore dynamics. The revised target implies roughly 8% downside to Rio Tinto's Feb. 23 close of 7,162p. Barclays also flagged constrained long-term copper gr…
Main Street Capital (MAIN) offers a high single-digit yield with a conservative balance sheet, reasonable valuation and an attractive entry after a recent pullback. For investors looking to complement bond holdings with equity income and modest capital upside, MAIN provides a trade-able setup with clear entry, stop and target.
Citizens reiterated a Market Outperform rating on ACV Auctions (ACVA) and kept an $8.00 price target, pointing to the companys proprietary, lot-level data as a material competitive advantage. InvestingPro places a Fair Value at $8.40, implying the stock remains undervalued relative to its current trading level. ACV reported mixed fourth-quarter 20…
Nebius is executing a blitz buildout of GPU-powered data centers and is benefiting from outsized hyperscaler spending. Revenue and ARR trajectories look explosive on paper, but high valuation and capital intensity make this a high-risk, high-reward swing trade. Entry, target, and stop are provided with a 45-trading-day horizon and explicit risks to…
JPMorgan moved Novo Nordisk to Neutral from Overweight and trimmed its price target to 250 Danish crowns from 350 after late-stage REDEFINE-4 data suggested CagriSema is less competitive than Eli Lilly’s Zepbound. The bank significantly reduced sales and earnings forecasts for Novo across the 2026-2030 period, and shares fell in Copenhagen trading.…
Piper Sandler has initiated coverage of Cactus, Inc. (NYSE:WHD) with an Overweight rating and a $73.00 price target, basing the valuation on 12 times 2027 estimated EBITDA. The firm points to Cactus’s low leverage, ample liquidity and strategic acquisitions as foundations for margin expansion and free cash flow generation, while noting ongoing tari…
Freight rates for the largest oil tankers have climbed to their highest level in six years as a spike in crude shipments from the Gulf coincides with traders booking ships sooner amid the threat of U.S.-Iran military confrontation. A mix of stronger Middle Eastern exports, shifting buyer preferences, shrinking available tonnage and fears around war…
Celsius has stabilized after the post-inventory shake-up with PepsiCo and shows signs of re-accelerating revenue and cash generation. The market is pricing strong growth into the stock (market cap ~$12.7B), but near-term technicals and improving fundamentals create a practical swing trade with defined risk.
Danaos (DAC) is trading near $108 but sits on a $4.3 billion contracted revenue backlog, reported adjusted EPS of $7.14 in Q4 2025 and holds $1.4 billion of liquidity. Management is returning capital aggressively while expanding contracted coverage and the fleet. Given a cheap multiple (PE ~4.1, PB ~0.54) and improving technical momentum, this trad…
Shares in Finnish asset manager Mandatum dropped sharply after private equity firm Altor sold a significant block of the company’s stock. Altor disposed of 35 million shares at €6.80 apiece, raising about €238 million (around 2.5 billion Swedish crowns). The placement, arranged by Citi and SEB, represented roughly 7% of Mandatum’s share capital and…
Raymond James upgraded Genuine Parts Company (GPC) from Market Perform to Strong Buy and assigned a $145 price target based on a sum-of-the-parts valuation. The stock, trading near $116.16, implies roughly 25% upside to the target. The analyst's model assumes specific valuation multiples for the company’s Motion, North America Auto, and Internation…
Deutsche Bank cut its price target on Johnson Matthey to GBP21.20 from GBP24.00 while keeping a Buy rating after updating its model to reflect renegotiated terms on the sale of the Catalyst Technologies business to Honeywell. The revised transaction value and lower expected net proceeds weigh on the valuation, although InvestingPro data indicates t…
Deutsche Bank downgraded Rentokil Initial Plc. to Hold from Buy and cut its price target to GBP4.65 from GBP5.05, citing a margin gap in the Pest Control category versus international peers and uncertainty around how the incoming CEO will close that gap. The broker flagged potential near-term pressure from investments to lift organic growth. Separa…
Seaport Global upgraded FOX Corp. (NASDAQ: FOXA) to Buy from Neutral and set a $64 price target, arguing that the post-earnings selloff tied to sports-betting exposure fears and an accelerated buyback has been overextended. The firm pointed to upcoming sports programming and the election cycle as advertising catalysts, while other brokers have also…
Citizens has begun coverage of Sionna Therapeutics (NASDAQ: SION) with a Market Outperform rating and a $63.00 price target derived from a risk-adjusted discounted cash flow model. With the stock trading at $36.10, Citizens’ target implies about 75% upside. Sionna’s shares have risen strongly over the past year, but other analysts differ on valuati…
U.S. equity futures were largely flat as investors awaited a busy week of corporate earnings, with concerns about potential disruptions from artificial intelligence weighing on sentiment. President Donald Trump’s 10% global tariffs took effect after a Supreme Court ruling curtailed his broader emergency-powers levies. Meanwhile, Paramount Skydance …
The U.S. dollar ticked up modestly on Tuesday, reversing some of Monday’s decline as uncertainty around the administration’s revised tariff approach reverberated through markets. The Dollar Index rose slightly, while EUR/USD traded in a narrow range after comments from the European Central Bank president. Risk around global trade policy, mixed U.S.…
Barclays has moved PPL Corp to an Overweight rating from Equalweight and raised its price target to $40 from $37, citing clearer visibility on multi-year EPS growth after the utility extended its 6-8% annual EPS target through at least 2029. The company highlighted several sources of upside beyond guidance, including transmission wins, incremental …
Morgan Stanley has begun coverage of Grindr Inc. (GRND) with an Equalweight rating and a $14.00 price target. The stock trades at $11.26 and is identified by platform analysis as trading below its assessed fair value. The firm highlights Grindr's network effects, elevated user engagement and a 74.51% gross profit margin, while noting ongoing tensio…
Morgan Stanley began coverage of Venture Global (VG) with an underweight rating and an $8.00 price target, citing significant exposure of future sales to market pricing and a stretched balance sheet. The bank’s analysis highlights a sensitivity of EBITDA to changes in marketing margins, while acknowledging the company’s operational execution and gr…
Morgan Stanley downgraded Cheniere Energy to Equalweight from Overweight and cut its price target to $236 from $258, saying the stock's rally has pushed shares close to its assessment of fair value for the current portfolio. The firm removed pre-FID growth projects from its base case and flagged more muted near-term catalysts while keeping a 2026 E…
Barclays has slashed its peak sales projection for Novo Nordisk’s next-generation obesity treatment CagriSema to $2 billion from $12 billion after late-stage trial results revealed the drug underperformed Eli Lilly’s Zepbound. The data prompted notable analyst skepticism about CagriSema’s commercial prospects, large moves in both companies’ share p…
Baird raised its rating on KeyCorp (KEY) from Underperform to Neutral on Tuesday, assigning a $19.00 price target. The stock trades above that target at $21.01, while third-party fair-value data places intrinsic value higher at $28.45. The move comes after a broad regional bank sell-off and amid mixed signals from the company’s fourth-quarter 2025 …
